Literature DB >> 15661807

Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells.

Rafael Mayoral1, Amalia Fernández-Martínez, Lisardo Boscá, Paloma Martín-Sanz.   

Abstract

The effect of the expression of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) synthesis on cell migration, the secretion of matrix metalloproteinases (MMPs) and the adhesion of human hepatoma cell lines has been investigated. A close correlation was observed between the expression of COX-2 under basal conditions and the secretion of MMP-2 and MMP-9. Cell migration in HuH-7 cells, which express high constitutive levels of COX-2 was significantly inhibited by selective inhibitors of COX-2 and enhanced by exogenous addition of PGE2. Hepatocellular carcinoma (HCC) cells expressed beta1 and alphaV beta3 integrins, exhibiting an increase in cell adhesion onto fibronectin and vitronectin. Moreover, addition of PGE2 increased the beta1 integrin levels and adhesion on vitronectin in HuH-7 cells. Inhibitors of MEK/ERK, p38 MAPK, protein kinases A and C impaired the migration of HuH-7 cells induced by PGE2, indicating the involvement of multiple pathways in the process. Taken together, these results support the existence of a relationship between COX-2-derived PGE2 synthesis, and migration and adhesion through an integrin-dependent pathway in HCC cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661807     DOI: 10.1093/carcin/bgi022

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  32 in total

1.  R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.

Authors:  Jaideep Behari; Gang Zeng; Wade Otruba; Michael D Thompson; Peggy Muller; Amanda Micsenyi; Sandeep S Sekhon; Lorenzo Leoni; Satdarshan P S Monga
Journal:  J Hepatol       Date:  2006-12-21       Impact factor: 25.083

2.  The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.

Authors:  M Zhou; M T Mok; H Sun; A W Chan; Y Huang; A S Cheng; G Xu
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

3.  Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.

Authors:  Jian-Feng Qiu; Ke-Lin Zhang; Xiao-Jing Zhang; Yuan-Jia Hu; Peng Li; Chang-Zhen Shang; Jian-Bo Wan
Journal:  Lipids       Date:  2015-08-21       Impact factor: 1.880

Review 4.  Cyclooxygenases in hepatocellular carcinoma.

Authors:  Melchiorre Cervello; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

5.  MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis.

Authors:  YiQing Li; SongMei Yin; DaNian Nie; ShuangFeng Xie; LiPing Ma; XiuJu Wang; YuDan Wu; Jie Xiao
Journal:  Int J Hematol       Date:  2011-10-29       Impact factor: 2.490

6.  αv integrin: a new gastrin target in human pancreatic cancer cells.

Authors:  Celine Cayrol; Claudine Bertrand; Aline Kowalski-Chauvel; Laurence Daulhac; Elizabeth Cohen-Jonathan-Moyal; Audrey Ferrand; Catherine Seva
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

7.  Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis.

Authors:  Cristina Llorente Izquierdo; Rafael Mayoral; Juana María Flores; Pilar García-Palencia; Carme Cucarella; Lisardo Boscá; Marta Casado; Paloma Martín-Sanz
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

8.  TNF-α stimulates colonic myofibroblast migration via COX-2 and Hsp27.

Authors:  Shyla Saini; Tiegang Liu; James Yoo
Journal:  J Surg Res       Date:  2016-04-25       Impact factor: 2.192

9.  Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.

Authors:  David F Schaeffer; Kiran Assi; Katie Chan; Andrzej K Buczkowski; Stephen W Chung; Charles H Scudamore; Alan Weiss; Bill Salh; David A Owen
Journal:  Virchows Arch       Date:  2010-01-21       Impact factor: 4.064

10.  Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.

Authors:  Qing-Hui Zhou; Ye-Zi You; Chao Wu; Yi Huang; David Oupický
Journal:  J Drug Target       Date:  2009-06       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.